天合光能(688599.SH)與通威股份下屬簽訂採購框架合同
格隆匯11月17日丨天合光能(688599.SH)公佈,公司與通威股份下屬永祥多晶硅、永祥新能源、內蒙通威、雲南通威就2021-2023年硅料購銷事宜簽訂《硅料戰略合作框架協議》。合同約定2021年1月-2023年12月期間,天合光能向通威股份下屬永祥多晶硅、永祥新能源、內蒙通威、雲南通威採購多晶硅合計約72,000噸。
公司在2021年底光伏組件產能規劃不低於50GW,未來將繼續夯實基於大尺寸電池的先進組件產能規模優勢。本次長單採購合同的簽訂將有助於公司及時有效應對市場環境變化,為公司供應鏈的長期穩定提供有力保障,符合公司未來發展戰略規劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.